Middle East Pharmaceutical Industries Company Return on Equity

Middle East Pharmaceutical Industries Company's return on equity stands at 24.35%. That is above the sector sector average of 11.85%. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

Middle East Pharmaceutical Industries Company sits higher the its sector benchmark (11.85%) with a ROE of 24.35%. That is roughly 105.5% above the sector mean. Peer context matters because what looks expensive or cheap in absolute terms can be normal for the sector.

A ROE of 24.35% for Middle East Pharmaceutical Industries Company means each unit of related capital or sales is generating that return rate. Higher is usually better for profitability metrics, but extremely high figures can reflect one-time items or thin equity bases. Review several years of data on this page before extrapolating.

The history chart shows how Middle East Pharmaceutical Industries Company's ROE evolved across reporting periods, while the comparison chart places 4016.SR next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.